iFuse 3D
Sacroiliac Joint Dysfunction
Key Facts
Indication
Sacroiliac Joint Dysfunction
Phase
Approved
Status
Marketed; 5-year follow-up ongoing
Company
About SI-BONE
SI-BONE is a leader in developing and commercializing minimally invasive solutions for sacroiliac joint dysfunction, a condition implicated in 15-30% of chronic low back pain cases. Founded in 2009, the company has established a robust clinical foundation for its iFuse Implant System, including multiple randomized controlled trials and over a hundred peer-reviewed publications. As a publicly traded entity, SI-BONE continues to invest in clinical research and expand its product portfolio to solidify its market position and address adjacent indications like pelvic trauma and spinopelvic fixation.
View full company profileTherapeutic Areas
Other Sacroiliac Joint Dysfunction Drugs
| Drug | Company | Phase |
|---|---|---|
| iFuse TORQ Implant System | SI-BONE | Approved |